RUTW240712C2000000
- 152.53
- +29.48+23.96%
Russell 2000 Index Newsroom
Patterson-UTI Energy Analyst Ratings
Oil States International Analyst Ratings
Liberty Energy Analyst Ratings
Morgan Stanley Raises Price Target on Treace Medical Concepts to $8 From $5.50, Keeps Equalweight Rating
Jefferies Downgrades Morphic Holding to Hold From Buy, Price Target Is $57
Helmerich & Payne Analyst Ratings
Morgan Stanley Boosts Price Target on TransMedics Group to $145 From $104, Keeps Equalweight Rating
Core Laboratories Analyst Ratings
Morgan Stanley Lowers Price Target on SI-Bone to $21 From $25, Keeps Overweight Rating
Truist Financial Reaffirms Their Buy Rating on Corcept Therapeutics (CORT)
Truist Financial Keeps Their Buy Rating on Instructure Holdings (INST)
ChampionX Analyst Ratings
Jefferies Downgrades Armada Hoffler Properties to Hold From Buy, Adjusts Price Target to $11 From $13
Morgan Stanley Cuts Price Target on Nevro to $9 From $14, Keeps Equalweight Rating
Atlas Energy Solutions Analyst Ratings
Morgan Stanley Cuts Price Target on IRhythm Technologies to $130 From $135, Keeps Overweight Rating
ProFrac Holding Analyst Ratings
Morgan Stanley Raises Price Target on Integra LifeSciences to $27 From $24, Keeps Underweight Rating
Morgan Stanley Raises Price Target on Inari Medical to $60 From $55, Keeps Overweight Rating
JPMorgan Downgrades Altair Engineering to Neutral From Overweight, Price Target Is $95